Selected research
Industry Research
Velcade Industry Research Report 2026
Market perspective
The global Velcade market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Velcade is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Velcade is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Velcade is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Velcade include Ben Venue Laboratories, Hospira, Beijing Shuanglu Pharmaceutical, Guangdong Lingnan Pharmaceutical, Sinopharm Pharmaceutical, Harbin Sanlian Pharmaceutical, XISUN, Nanjing Zhengda Tianqing Pharmaceutical and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Velcade market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Velcade Market by Company
Ben Venue Laboratories
Hospira
Beijing Shuanglu Pharmaceutical
Guangdong Lingnan Pharmaceutical
Sinopharm Pharmaceutical
Harbin Sanlian Pharmaceutical
XISUN
Nanjing Zhengda Tianqing Pharmaceutical
Johnson & Johnson
Shandong Luoxin Pharmaceutical Group
Shanxi Pude Pharmaceutical
Wuhan Renfu Pharmaceutical
Takeda
Xi'an Yangsen Pharmaceutical
Velcade Segment by Type
1.0 Mg Injection
3.5 Mg Injection
Velcade Segment by Application
Multiple Myeloma
Mantle Cell Lymphoma
Velcade Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Velcade market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Velcade and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Velcade.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Velcade manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Velcade by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Velcade in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1.0 Mg Injection
- 3.5 Mg Injection
Applications
- Multiple Myeloma
- Mantle Cell Lymphoma
Companies covered
- Ben Venue Laboratories
- Hospira
- Beijing Shuanglu Pharmaceutical
- Guangdong Lingnan Pharmaceutical
- Sinopharm Pharmaceutical
- Harbin Sanlian Pharmaceutical
- XISUN
- Nanjing Zhengda Tianqing Pharmaceutical
- Johnson & Johnson
- Shandong Luoxin Pharmaceutical Group
- Shanxi Pude Pharmaceutical
- Wuhan Renfu Pharmaceutical
- Takeda
- Xi'an Yangsen Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Velcade Market Size (2021-2032)
- 2.2.2 Global Velcade Sales (2021-2032)
- 2.2.3 Global Velcade Market Average Price (2021-2032)
- 2.3 Velcade by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1.0 Mg Injection
- 2.3.3 3.5 Mg Injection
- 2.4 Velcade by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Multiple Myeloma
- 2.4.3 Mantle Cell Lymphoma
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Velcade Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Velcade Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Velcade Revenue of Manufacturers (2021-2026)
- 3.4 Global Velcade Average Price by Manufacturers (2021-2026)
- 3.5 Global Velcade Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Velcade, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Velcade, Product Type & Application
- 3.8 Global Manufacturers of Velcade, Established Date
- 3.9 Global Velcade Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ben Venue Laboratories
- 4.1.1 Ben Venue Laboratories Company Information
- 4.1.2 Ben Venue Laboratories Business Overview
- 4.1.3 Ben Venue Laboratories Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ben Venue Laboratories Velcade Product Portfolio
- 4.1.5 Ben Venue Laboratories Recent Developments
- 4.2 Hospira
- 4.2.1 Hospira Company Information
- 4.2.2 Hospira Business Overview
- 4.2.3 Hospira Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hospira Velcade Product Portfolio
- 4.2.5 Hospira Recent Developments
- 4.3 Beijing Shuanglu Pharmaceutical
- 4.3.1 Beijing Shuanglu Pharmaceutical Company Information
- 4.3.2 Beijing Shuanglu Pharmaceutical Business Overview
- 4.3.3 Beijing Shuanglu Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beijing Shuanglu Pharmaceutical Velcade Product Portfolio
- 4.3.5 Beijing Shuanglu Pharmaceutical Recent Developments
- 4.4 Guangdong Lingnan Pharmaceutical
- 4.4.1 Guangdong Lingnan Pharmaceutical Company Information
- 4.4.2 Guangdong Lingnan Pharmaceutical Business Overview
- 4.4.3 Guangdong Lingnan Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Guangdong Lingnan Pharmaceutical Velcade Product Portfolio
- 4.4.5 Guangdong Lingnan Pharmaceutical Recent Developments
- 4.5 Sinopharm Pharmaceutical
- 4.5.1 Sinopharm Pharmaceutical Company Information
- 4.5.2 Sinopharm Pharmaceutical Business Overview
- 4.5.3 Sinopharm Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sinopharm Pharmaceutical Velcade Product Portfolio
- 4.5.5 Sinopharm Pharmaceutical Recent Developments
- 4.6 Harbin Sanlian Pharmaceutical
- 4.6.1 Harbin Sanlian Pharmaceutical Company Information
- 4.6.2 Harbin Sanlian Pharmaceutical Business Overview
- 4.6.3 Harbin Sanlian Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Harbin Sanlian Pharmaceutical Velcade Product Portfolio
- 4.6.5 Harbin Sanlian Pharmaceutical Recent Developments
- 4.7 XISUN
- 4.7.1 XISUN Company Information
- 4.7.2 XISUN Business Overview
- 4.7.3 XISUN Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 XISUN Velcade Product Portfolio
- 4.7.5 XISUN Recent Developments
- 4.8 Nanjing Zhengda Tianqing Pharmaceutical
- 4.8.1 Nanjing Zhengda Tianqing Pharmaceutical Company Information
- 4.8.2 Nanjing Zhengda Tianqing Pharmaceutical Business Overview
- 4.8.3 Nanjing Zhengda Tianqing Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nanjing Zhengda Tianqing Pharmaceutical Velcade Product Portfolio
- 4.8.5 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments
- 4.9 Johnson & Johnson
- 4.9.1 Johnson & Johnson Company Information
- 4.9.2 Johnson & Johnson Business Overview
- 4.9.3 Johnson & Johnson Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Johnson & Johnson Velcade Product Portfolio
- 4.9.5 Johnson & Johnson Recent Developments
- 4.10 Shandong Luoxin Pharmaceutical Group
- 4.10.1 Shandong Luoxin Pharmaceutical Group Company Information
- 4.10.2 Shandong Luoxin Pharmaceutical Group Business Overview
- 4.10.3 Shandong Luoxin Pharmaceutical Group Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shandong Luoxin Pharmaceutical Group Velcade Product Portfolio
- 4.10.5 Shandong Luoxin Pharmaceutical Group Recent Developments
- 4.11 Shanxi Pude Pharmaceutical
- 4.11.1 Shanxi Pude Pharmaceutical Company Information
- 4.11.2 Shanxi Pude Pharmaceutical Business Overview
- 4.11.3 Shanxi Pude Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shanxi Pude Pharmaceutical Velcade Product Portfolio
- 4.11.5 Shanxi Pude Pharmaceutical Recent Developments
- 4.12 Wuhan Renfu Pharmaceutical
- 4.12.1 Wuhan Renfu Pharmaceutical Company Information
- 4.12.2 Wuhan Renfu Pharmaceutical Business Overview
- 4.12.3 Wuhan Renfu Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Wuhan Renfu Pharmaceutical Velcade Product Portfolio
- 4.12.5 Wuhan Renfu Pharmaceutical Recent Developments
- 4.13 Takeda
- 4.13.1 Takeda Company Information
- 4.13.2 Takeda Business Overview
- 4.13.3 Takeda Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Takeda Velcade Product Portfolio
- 4.13.5 Takeda Recent Developments
- 4.14 Xi'an Yangsen Pharmaceutical
- 4.14.1 Xi'an Yangsen Pharmaceutical Company Information
- 4.14.2 Xi'an Yangsen Pharmaceutical Business Overview
- 4.14.3 Xi'an Yangsen Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Xi'an Yangsen Pharmaceutical Velcade Product Portfolio
- 4.14.5 Xi'an Yangsen Pharmaceutical Recent Developments
5 Global Velcade Market Scenario by Region
- 5.1 Global Velcade Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Velcade Sales by Region: 2021-2032
- 5.2.1 Global Velcade Sales by Region: 2021-2026
- 5.2.2 Global Velcade Sales by Region: 2027-2032
- 5.3 Global Velcade Revenue by Region: 2021-2032
- 5.3.1 Global Velcade Revenue by Region: 2021-2026
- 5.3.2 Global Velcade Revenue by Region: 2027-2032
- 5.4 North America Velcade Market Facts & Figures by Country
- 5.4.1 North America Velcade Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Velcade Sales by Country (2021-2032)
- 5.4.3 North America Velcade Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Velcade Market Facts & Figures by Country
- 5.5.1 Europe Velcade Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Velcade Sales by Country (2021-2032)
- 5.5.3 Europe Velcade Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Velcade Market Facts & Figures by Country
- 5.6.1 Asia Pacific Velcade Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Velcade Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Velcade Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Velcade Market Facts & Figures by Country
- 5.7.1 South America Velcade Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Velcade Sales by Country (2021-2032)
- 5.7.3 South America Velcade Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Velcade Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Velcade Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Velcade Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Velcade Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Velcade Sales by Type (2021-2032)
- 6.1.1 Global Velcade Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Velcade Sales Market Share by Type (2021-2032)
- 6.2 Global Velcade Revenue by Type (2021-2032)
- 6.2.1 Global Velcade Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Velcade Revenue Market Share by Type (2021-2032)
- 6.3 Global Velcade Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Velcade Sales by Application (2021-2032)
- 7.1.1 Global Velcade Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Velcade Sales Market Share by Application (2021-2032)
- 7.2 Global Velcade Revenue by Application (2021-2032)
- 7.2.1 Global Velcade Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Velcade Revenue Market Share by Application (2021-2032)
- 7.3 Global Velcade Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Velcade Value Chain Analysis
- 8.1.1 Velcade Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Velcade Production Mode & Process
- 8.2 Velcade Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Velcade Distributors
- 8.2.3 Velcade Customers
9 Global Velcade Analyzing Market Dynamics
- 9.1 Velcade Industry Trends
- 9.2 Velcade Industry Drivers
- 9.3 Velcade Industry Opportunities and Challenges
- 9.4 Velcade Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst